Loading…

A novel MPTP primate model of Parkinson's disease: neurochemical and clinical changes

Positron emission tomography (PET) and the dopamine (DA) metabolism tracer, [ 18 F] 6-fluoro- l- m-tyrosine (FMT) were used to evaluate the relationship between DA metabolism and the clinical stage of parkinsonism monkeys following either unilateral ICA MPTP infusion or unilateral ICA MPTP infusion...

Full description

Saved in:
Bibliographic Details
Published in:Brain research 1998-09, Vol.805 (1), p.259-262
Main Authors: Eberling, Jamie L., Jagust, William J., Taylor, Scott, Bringas, John, Pivirotto, Phillip, VanBrocklin, Henry F., Bankiewicz, Krys S.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Positron emission tomography (PET) and the dopamine (DA) metabolism tracer, [ 18 F] 6-fluoro- l- m-tyrosine (FMT) were used to evaluate the relationship between DA metabolism and the clinical stage of parkinsonism monkeys following either unilateral ICA MPTP infusion or unilateral ICA MPTP infusion and subsequent varying sequential systemic doses of MPTP. Clinical stage corresponded to PET measures of striatal DA metabolism, showing the usefulness of the overlesioned hemiparkinsonian monkey as a stable model of various stages of Parkinson's disease (PD).
ISSN:0006-8993
1872-6240
DOI:10.1016/S0006-8993(98)00710-0